Download Unicorn Signals App

Powered By EquityPandit
 Signals, Powered By  EquityPandit
BUSINESS

Lupin to Enter Digital Healthcare Space

Lupin Ltd.'s plant stands in Goa, India, in this 2011 handout photograph released to the media on July 27, 2012. Lupin Ltd., the world's biggest maker of drugs to treat tuberculosis, plans to acquire brands in the U.S. to reduce its reliance on less profitable generic medicines, President Nilesh Gupta said. Source: Lupin Ltd. via Bloomberg EDITOR'S NOTE: NO SALES. EDITORIAL USE ONLY.

Drug major Lupin Ltd has said it will enter the digital healthcare space in India with a focus to provide a digital therapeutics platform for doctors and patients. In a regulatory filing, the company said “the board of directors has approved the company’s entry into the digital healthcare space…”

The company said it has recently incorporated a new entity in the name of Lupin Digital Health Ltd, as a wholly-owned subsidiary, which will undertake this, the filing added. Lupin, however, did not share any other details about the new venture. Shares of Lupin Ltd were trading 0.29 per cent lower at Rs 1,243.30 apiece on BSE.

Stock Covered in the news

Lupin Ltd-View Detailed Analysis

Get Daily Prediction & Stocks Tips On Your Mobile